Dongwha Pharm.Co.Ltd (000020) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.002x

Based on the latest financial reports, Dongwha Pharm.Co.Ltd (000020) has a cash flow conversion efficiency ratio of 0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩697.02 Million ≈ $472.36K USD) by net assets (₩409.65 Billion ≈ $277.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000020 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Dongwha Pharm.Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Dongwha Pharm.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dongwha Pharm.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongwha Pharm.Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Eimco Elecon (India) Limited NSE:EIMCOELECO	0.013x
Vivani Medical Inc. NASDAQ:VANI	-0.427x
Ctek AB ST:CTEK	0.182x
Edison Opto Corp TW:3591	0.012x
Vranken-Pommery Monopole Société Anonyme PA:VRAP	-0.107x
Hyundai Everdigm Corp KQ:041440	-0.014x
CLERHP Estructuras S.A MC:CLR	-0.061x
MEI Pharma Inc NASDAQ:MEIP	-0.145x

Annual Cash Flow Conversion Efficiency for Dongwha Pharm.Co.Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Dongwha Pharm.Co.Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 000020 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩401.44 Billion ≈ $272.05 Million	₩15.70 Billion ≈ $10.64 Million	0.039x	+492.38%
2024-12-31	₩401.68 Billion ≈ $272.21 Million	₩-4.00 Billion ≈ $-2.71 Million	-0.010x	-113.91%
2023-12-31	₩407.06 Billion ≈ $275.86 Million	₩29.17 Billion ≈ $19.77 Million	0.072x	-7.15%
2022-12-31	₩378.67 Billion ≈ $256.62 Million	₩29.22 Billion ≈ $19.80 Million	0.077x	-22.87%
2021-12-31	₩360.13 Billion ≈ $244.06 Million	₩36.03 Billion ≈ $24.42 Million	0.100x	-34.35%
2020-12-31	₩342.68 Billion ≈ $232.23 Million	₩52.23 Billion ≈ $35.39 Million	0.152x	+245.17%
2019-12-31	₩300.87 Billion ≈ $203.90 Million	₩13.28 Billion ≈ $9.00 Million	0.044x	+401.18%
2018-12-31	₩297.40 Billion ≈ $201.54 Million	₩-4.36 Billion ≈ $-2.95 Million	-0.015x	+73.65%
2017-12-31	₩296.94 Billion ≈ $201.24 Million	₩-16.52 Billion ≈ $-11.20 Million	-0.056x	-155.22%
2016-12-31	₩252.93 Billion ≈ $171.40 Million	₩25.48 Billion ≈ $17.27 Million	0.101x	+16.90%
2015-12-31	₩230.12 Billion ≈ $155.95 Million	₩19.83 Billion ≈ $13.44 Million	0.086x	+46.50%
2014-12-31	₩229.73 Billion ≈ $155.68 Million	₩13.51 Billion ≈ $9.16 Million	0.059x	+62.92%
2013-12-31	₩227.23 Billion ≈ $153.99 Million	₩8.21 Billion ≈ $5.56 Million	0.036x	-67.51%
2012-12-31	₩226.99 Billion ≈ $153.83 Million	₩25.23 Billion ≈ $17.10 Million	0.111x	-44.82%
2011-12-31	₩229.62 Billion ≈ $155.61 Million	₩46.24 Billion ≈ $31.34 Million	0.201x	--

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$100.87 Million

₩148.85 Billion KRW

Market Cap Rank

#19241 Global

#952 in Korea

Share Price

₩5370.00

Change (1 day)

+0.00%

52-Week Range

₩5210.00 - ₩7060.00

All Time High

₩28554.43